SenzaGen AB (OSTO:SENZA) Retained Earnings: kr-222.82 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:SENZA SenzaGen AB OSTO:SENZA
71 GF Score
Price kr4.98
GF Value kr6.29
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is SenzaGen AB Retained Earnings?

SenzaGen AB OSTO:SENZA -0.40% 71 Retained Earnings is kr-222.82 Mil as of Jun. 2026. GuruFocus rates OSTO:SENZA with a GF Score™ of 71/100 and a GF Value™ of kr6.29 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. SenzaGen AB's retained earnings for the quarter that ended in Jun. 2026 was kr-222.82 Mil.

SenzaGen AB's quarterly retained earnings declined from Dec. 2025 (kr-218.65 Mil) to Mar. 2026 (kr-220.90 Mil) and declined from Mar. 2026 (kr-220.90 Mil) to Jun. 2026 (kr-222.82 Mil).

SenzaGen AB's annual retained earnings declined from Dec. 2023 (kr62.62 Mil) to Dec. 2024 (kr-206.21 Mil) and declined from Dec. 2024 (kr-206.21 Mil) to Dec. 2025 (kr-218.65 Mil).


SenzaGen AB  (OSTO:SENZA) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


SenzaGen AB Retained Earnings Historical Data

* Premium members only.

The historical data trend for SenzaGen AB's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SenzaGen AB Retained Earnings Chart

SenzaGen AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 105.61 83.99 62.62 -206.21 -218.65

SenzaGen AB Quarterly Data
Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only -213.17 0.00 -218.65 -220.90 -222.82
OSTO:SENZA
71GF Score
SenzaGen AB OSTO:SENZA
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SenzaGen AB Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of kr-222.82 Mil mean?
SenzaGen AB (OSTO:SENZA) has a Retained Earnings of kr-222.82 Mil as of Jun. 2026. Retained earnings is the amount of net income not issued to shareholders. View historical data on SenzaGen AB and its competitors.
Is SenzaGen AB's Retained Earnings too high?
SenzaGen AB's current Retained Earnings is kr-222.82 Mil. Overall, SenzaGen AB has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SenzaGen AB's Retained Earnings compare to TMO and DHR?
SenzaGen AB's Retained Earnings of kr-222.82 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Medical Diagnostics & Research company?
A good Retained Earnings depends on the Medical Diagnostics & Research industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on SenzaGen AB and its competitors. SenzaGen AB's current Retained Earnings is kr-222.82 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SenzaGen AB stock overvalued right now?
Based on GuruFocus' analysis, SenzaGen AB (OSTO:SENZA) is currently considered Modestly Undervalued. The stock's GF Value™ is kr6.29, compared to a current price of kr4.98 — trading 20.8% below its estimated fair value. The current Retained Earnings is kr-222.82 Mil. SenzaGen AB's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For SenzaGen AB (OSTO:SENZA), the current Retained Earnings is kr-222.82 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SenzaGen AB (OSTO:SENZA) Overvalued in 2026?

Based on GuruFocus' analysis, SenzaGen AB stock appears to be undervalued. The current stock price of kr4.98 is trading 20.8% below its estimated GF Value™ of kr6.29. GuruFocus considers SenzaGen AB to be Modestly Undervalued.

Key valuation signals for OSTO:SENZA:

  • Retained Earnings: kr-222.82 Mil
  • GF Value™: kr6.29 vs. price of kr4.98 (20.8% below fair value)
  • GF Score™: 71/100 with 5 warning signs

No single metric tells the full story. See the OSTO:SENZA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


SenzaGen AB Business Description

Address Scheelevagen 8, Medicon Village, Building 401, Lund, SWE, 223 63
SenzaGen AB markets, sells, and performs in vitro testing using its Genomic Allergen Rapid Detection (GARD) platform through its laboratory and a network of contract research organizations. The company provides animal-free testing solutions for chemical compounds used in industries such as cosmetics, chemicals, pharmaceuticals, medical devices, and food and nutrition. Geographically, it operates in the Americas, EMEA, and APAC, with the majority of revenue from EMEA.
71GF Score

Get the complete analysis for OSTO:SENZA

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr4.98
Price
kr6.29
GF Value